Royalty Pharma in $6.6 Billion Bid for Elan
February 25, 2013 at 06:01 AM EST
Investment firm Royalty Pharma has made a $6.6 billion bid approach to Elan, seeking to scupper the Irish drugmaker's plan to spend most of the proceeds from a major drug sale on deals and instead give the money to shareholders.
